Selectis Health (GBCS) Cost of Revenue (2015 - 2025)

Selectis Health has disclosed Cost of Revenue across 11 years of filings, most recently posting $7.0 million for Q4 2025.

• Cost of Revenue for Q4 2025 came in at $7.0 million, down 10.99% year-over-year; the trailing twelve-month figure through Dec 2025 was $31.8 million (up 4.61% YoY), and the FY2025 annual result was $31.8 million, up 4.61% from the prior year.
• Cost of Revenue came in at $7.0 million for Q4 2025 at Selectis Health, down from $8.5 million in the prior quarter.
• In the past five years, Cost of Revenue ranged from a high of $8.9 million in Q4 2021 to a low of $3.5 million in Q1 2021.
• The 5-year median for Cost of Revenue is $7.5 million (2024), against an average of $7.2 million.
• Across the five-year window, Cost of Revenue soared 96.4% in 2022 and slipped 11.85% in 2024, its largest moves.
• Selectis Health's Cost of Revenue stood at $8.9 million in 2021, then dropped by 2.18% to $8.7 million in 2022, then retreated by 10.66% to $7.7 million in 2023, then rose by 1.61% to $7.9 million in 2024, then dropped by 10.99% to $7.0 million in 2025.
• The last three Cost of Revenue figures came in at $7.0 million (Q4 2025), $8.5 million (Q3 2025), and $8.2 million (Q2 2025), per Business Quant data.